Overcoming challenges of venous thromboembolism in sickle cell disease treatment

Foluso Joy Ogunsile, Rakhi Prakash Naik, Sophie Lanzkron

Research output: Contribution to journalReview article

Abstract

Introduction: Venous thromboembolism (VTE) is a common comorbid condition found in sickle cell disease (SCD) and is associated with increased mortality for adults with SCD. The pathophysiology that leads to the thrombophilic state in SCD has been previously reviewed; however, evidence-based guidelines to aid in diagnosis, prevention, and management of VTE are lacking. Areas covered: This review article will cover the pathophysiology underlying the hypercoagulable state, the epidemiology of VTE, and management strategies of VTE in SCD. Expert opinion: Providers should have a high suspicion for diagnosing VTE to help reduce morbidity and mortality in the SCD population. Unlike other thrombophilias, the risk of life-threatening anemia while being treated with anticoagulation is compounded with the potential complications surrounding red blood cell transfusions in this population (i.e. alloimmunization, hyperhemolysis) and this provides another complexity to managing VTE in this population. Clinical trials evaluating the risk and benefit of treatment and treatment duration are needed.

Original languageEnglish (US)
Pages (from-to)173-182
Number of pages10
JournalExpert review of hematology
Volume12
Issue number3
DOIs
StatePublished - Mar 4 2019

Fingerprint

Venous Thromboembolism
Sickle Cell Anemia
Therapeutics
Population
Erythrocyte Transfusion
Mortality
Expert Testimony
Anemia
Epidemiology
Clinical Trials
Guidelines
Morbidity

Keywords

  • deep venous thrombosis
  • epidemiology of venous thromboembolism in sickle cell disease
  • management of venous thromboembolism in sickle cell disease
  • pulmonary embolism
  • Sickle cell disease
  • venous thromboembolism

ASJC Scopus subject areas

  • Hematology

Cite this

Overcoming challenges of venous thromboembolism in sickle cell disease treatment. / Ogunsile, Foluso Joy; Naik, Rakhi Prakash; Lanzkron, Sophie.

In: Expert review of hematology, Vol. 12, No. 3, 04.03.2019, p. 173-182.

Research output: Contribution to journalReview article

@article{cb002e71712a45a4b705e4b471bd2666,
title = "Overcoming challenges of venous thromboembolism in sickle cell disease treatment",
abstract = "Introduction: Venous thromboembolism (VTE) is a common comorbid condition found in sickle cell disease (SCD) and is associated with increased mortality for adults with SCD. The pathophysiology that leads to the thrombophilic state in SCD has been previously reviewed; however, evidence-based guidelines to aid in diagnosis, prevention, and management of VTE are lacking. Areas covered: This review article will cover the pathophysiology underlying the hypercoagulable state, the epidemiology of VTE, and management strategies of VTE in SCD. Expert opinion: Providers should have a high suspicion for diagnosing VTE to help reduce morbidity and mortality in the SCD population. Unlike other thrombophilias, the risk of life-threatening anemia while being treated with anticoagulation is compounded with the potential complications surrounding red blood cell transfusions in this population (i.e. alloimmunization, hyperhemolysis) and this provides another complexity to managing VTE in this population. Clinical trials evaluating the risk and benefit of treatment and treatment duration are needed.",
keywords = "deep venous thrombosis, epidemiology of venous thromboembolism in sickle cell disease, management of venous thromboembolism in sickle cell disease, pulmonary embolism, Sickle cell disease, venous thromboembolism",
author = "Ogunsile, {Foluso Joy} and Naik, {Rakhi Prakash} and Sophie Lanzkron",
year = "2019",
month = "3",
day = "4",
doi = "10.1080/17474086.2019.1583554",
language = "English (US)",
volume = "12",
pages = "173--182",
journal = "Expert Review of Hematology",
issn = "1747-4086",
publisher = "Expert Reviews Ltd.",
number = "3",

}

TY - JOUR

T1 - Overcoming challenges of venous thromboembolism in sickle cell disease treatment

AU - Ogunsile, Foluso Joy

AU - Naik, Rakhi Prakash

AU - Lanzkron, Sophie

PY - 2019/3/4

Y1 - 2019/3/4

N2 - Introduction: Venous thromboembolism (VTE) is a common comorbid condition found in sickle cell disease (SCD) and is associated with increased mortality for adults with SCD. The pathophysiology that leads to the thrombophilic state in SCD has been previously reviewed; however, evidence-based guidelines to aid in diagnosis, prevention, and management of VTE are lacking. Areas covered: This review article will cover the pathophysiology underlying the hypercoagulable state, the epidemiology of VTE, and management strategies of VTE in SCD. Expert opinion: Providers should have a high suspicion for diagnosing VTE to help reduce morbidity and mortality in the SCD population. Unlike other thrombophilias, the risk of life-threatening anemia while being treated with anticoagulation is compounded with the potential complications surrounding red blood cell transfusions in this population (i.e. alloimmunization, hyperhemolysis) and this provides another complexity to managing VTE in this population. Clinical trials evaluating the risk and benefit of treatment and treatment duration are needed.

AB - Introduction: Venous thromboembolism (VTE) is a common comorbid condition found in sickle cell disease (SCD) and is associated with increased mortality for adults with SCD. The pathophysiology that leads to the thrombophilic state in SCD has been previously reviewed; however, evidence-based guidelines to aid in diagnosis, prevention, and management of VTE are lacking. Areas covered: This review article will cover the pathophysiology underlying the hypercoagulable state, the epidemiology of VTE, and management strategies of VTE in SCD. Expert opinion: Providers should have a high suspicion for diagnosing VTE to help reduce morbidity and mortality in the SCD population. Unlike other thrombophilias, the risk of life-threatening anemia while being treated with anticoagulation is compounded with the potential complications surrounding red blood cell transfusions in this population (i.e. alloimmunization, hyperhemolysis) and this provides another complexity to managing VTE in this population. Clinical trials evaluating the risk and benefit of treatment and treatment duration are needed.

KW - deep venous thrombosis

KW - epidemiology of venous thromboembolism in sickle cell disease

KW - management of venous thromboembolism in sickle cell disease

KW - pulmonary embolism

KW - Sickle cell disease

KW - venous thromboembolism

UR - http://www.scopus.com/inward/record.url?scp=85063140110&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063140110&partnerID=8YFLogxK

U2 - 10.1080/17474086.2019.1583554

DO - 10.1080/17474086.2019.1583554

M3 - Review article

C2 - 30773073

AN - SCOPUS:85063140110

VL - 12

SP - 173

EP - 182

JO - Expert Review of Hematology

JF - Expert Review of Hematology

SN - 1747-4086

IS - 3

ER -